This bill delays two Medicare billing deadlines for ground ambulance services from 2025 to 2028. It amends the Social Security Act to extend the timeline for implementing specific billing rules under Section 1834(l). The change directly affects Medicare ambulance providers by postponing compliance deadlines for billing requirements. No new services or funding are created - only a technical extension of existing timelines.
This bill amends the tax code to permanently establish a 7-year depreciation period for motorsports entertainment complexes, replacing a temporary provision. It directly affects businesses operating these facilities by allowing them to deduct the cost of qualifying assets over seven years instead of a shorter period. The key change is removing a temporary rule (subparagraph D) from the tax code, making the longer recovery period permanent for these specific properties. The bill focuses solely on clarifying and extending this tax treatment without additional policy changes.
Preserving Patient Access to Home Infusion Act This bill specifically includes pharmacy services and home infusion drugs that are administered without a pump as part of covered home infusion therapy under Medicare. The bill also allows nurses and physician assistants to establish and review the plan of care for home infusion therapy, and it specifies that payment may be made regardless of whether a practitioner is physically present in the home at the time the drug is administered.
The Medical Supply Chain Resiliency Act (HR 2213) establishes a framework for the U.S. to form agreements with foreign countries that commit to reliable medical supply chains during emergencies. It allows the President to negotiate "trusted trade partner agreements" that reduce trade barriers (like duties and quotas) for medical goods with countries meeting specific criteria, such as maintaining open trade during health crises and protecting intellectual property. These agreements require Congressional review and approval, with ongoing monitoring to ensure partners uphold commitments. The bill directly affects U.S. trade policy, foreign governments seeking partnerships, and the medical supply industry by aiming to diversify sources and secure critical products like pharmaceuticals and medical devices.
This bill repeals federal waivers that allow California to set its own vehicle and engine emission standards under the Clean Air Act. It directly affects California's Air Resources Board (CARB), prohibiting the state from adopting or enforcing standards for nonroad engines (like construction equipment, farm vehicles, and locomotives) or new motor vehicles. Key provisions include removing federal authorization for California's vehicle standards (Section 177) and invalidating all existing waivers for state emission rules. The bill would eliminate California's ability to enforce its own emission requirements for these categories, shifting authority entirely to federal standards.
S 1079, the Restoring Law and Order Act of 2025, creates a federal grant program to provide state and local law enforcement agencies (including tribal entities) with funding to address specific crime priorities. The grants fund hiring officers, targeting vehicle thefts and carjackings, prosecuting violent crime (including repeat offenders), using bail/pretrial detention for dangerous offenders, combating drug/fentanyl crimes, processing evidence faster, and deporting criminal aliens. The $500 million appropriation for fiscal year 2026 (with funds available until 2030) comes from rescinded unobligated balances previously allocated for diversity initiatives. Agencies receiving grants must maintain audit records and allow oversight of fund usage by the Attorney General.
HR 2143, the Small Business Transportation Investment Act of 2025, creates a 3-year pilot program allowing small businesses that provide paid ground transportation (such as taxis, shuttles, or non-emergency medical transport) to purchase vehicles through the General Services Administration's (GSA) existing procurement system at cost. This directly affects eligible small businesses meeting the Small Business Act definition, enabling them to access GSA's vehicle selection pool for fleet modernization. Key provisions require businesses to use purchased vehicles for at least two years, reimburse GSA if sold early, and donate one out of every five vehicles to nonprofits after use. The program includes annual reporting on cost savings, operational improvements, and environmental impacts, with a final report assessing whether to make it permanent.
Maintaining and Enhancing Hydroelectricity and River Restoration Act This bill establishes a new investment tax credit in the amount of 30% of the basis of any hydropower improvement property. The bill defines hydropower improvement property as property that adds or improves fish passage at a qualified dam; maintains or improves the quality of the water retained or released by a qualified dam; promotes downstream sediment transport and habitat maintenance; upgrades, repairs, or reconstructs a qualified dam to meet safety and security standards; improves public uses of, and access to, public waterways impacted by a qualified dam; removes an obsolete river obstruction; or places into service an approved remote dam. Further, written approval for hydropower improvement property must be obtained from the Federal Energy Regulatory Commission or state or local officials prior to January 1, 2032. The bill also allows an election to claim the investment tax credit for qualified progress expenses for some types of hydropower improvement property in advance of such property being placed into service. Any investment tax credit amount claimed for qualified progress expenses reduces the amount of the investment tax credit that may be claimed once the hydropower improvement property is placed into service. The bill authorizes certain entities, including tax-exempt and governmental entities, to treat the investment tax credit for hydropower improvement property as a payment of tax and receive a refund of any overpayment (also known as elective pay). Finally, the investment tax credit for hydropower improvement property may be transferred (i.e., sold).
The Stop CCP VISAs Act of 2025 would prohibit U.S. visas for Chinese citizens seeking to study or conduct research in the United States. It specifically blocks the issuance of F-1 (academic student), J-1 (exchange visitor), and M-1 (vocational student) visas for these purposes. This bill directly affects Chinese nationals who otherwise qualify for these student visa categories at U.S. educational institutions. The policy change would amend immigration law to implement this visa ban.
HR 2162, the Honey Integrity Act, requires U.S. honey packers to test honey for economically motivated adulteration (EMA) - such as substitution or dilution to increase value - using scientifically validated methods like DNA and NMR testing. Qualifying commercial honey packers (those paying fees to the National Honey Board) must conduct testing, certify compliance, and report results to the FDA within 180 days of the law’s enactment. The bill mandates immediate reporting of EMA findings to authorities and prohibits accepting adulterated honey, with the FDA required to investigate and share data with agencies like Customs and Agriculture. This directly affects honey packers in interstate commerce, aiming to improve product integrity through standardized testing and enforcement.
Radiation Oncology Case Rate Value Based Program Act of 2025 or the ROCR Value Based Program Act This bill establishes a specialized payment program under Medicare for providers and suppliers of radiation oncology services. Specifically, the Centers for Medicare & Medicaid Services (CMS) must establish a program under which radiation therapy providers (i.e., hospital outpatient departments) and suppliers (i.e., physician group practices and freestanding radiation therapy centers) receive payments for each episode of care provided to individuals with specified types of cancer. An episode of care means the period beginning on the day radiation therapy planning is furnished to the individual and ending (1) for individuals with bone or brain metastases, 30 days later; and (2) for individuals with other cancer types, 90 days later. Participation in the program is mandatory for providers and suppliers that participate in Medicare, unless the provider or supplier is part of a state-based Center for Medicare & Medicaid Innovation model or qualifies for a significant hardship exemption. The CMS must set payment rates for the program based on national payment rates with specified adjustments (e.g., geographic adjustments). Providers and suppliers who provide certain transportation services for individuals under their care may receive an additional payment. Providers and suppliers must be accredited in accordance with certain standards, subject to payment reductions. The Government Accountability Office must report on (1) implementation of the program, and (2) underserved areas that are in need of more or newer radiation therapy resources.
HR 2168, the BO’s Act, requires the Secretary of Health and Human Services to study home cardiorespiratory monitors used for infants. The study must assess the monitors' effectiveness in tracking heart rate and oxygen levels, evaluate new care models for safe infant sleep environments, and examine health insurance coverage criteria. A report on these findings must be submitted to Congress within one year of the bill’s enactment. This bill does not change current policy but aims to inform future decisions about monitor coverage and infant safety practices, directly affecting parents, healthcare providers, and insurers.
